Neuroendocrine Tumors, Version 1.2015

作者:Kulke Matthew H*; Shah Manisha H; Benson Al B III; Bergsland Emily; Berlin Jordan D; Blaszkowsky Lawrence S; Emerson Lyska; Engstrom Paul F; Fanta Paul; Giordano Thomas; Goldner Whitney S; Halfdanarson Thorvardur R; Heslin Martin J; Kandeel Fouad; Kunz Pamela L; Kuvshinoff Boris W II; Lieu Christopher; Moley Jeffery F; Munene Gitonga; Pillarisetty Venu G; Saltz Leonard; Sosa Julie Ann; Stro**erg Jonathan R; Vauthey Jean Nicolas; Wolfgang Christopher
来源:Journal of the National Comprehensive Cancer Network, 2015, 13(1): 78-108.
DOI:10.6004/jnccn.2015.0011

摘要

Neuroendocrine tumors (NETs) comprise a broad family of tumors that may or may not be associated with symptoms attributable to hormonal hypersecretion. The NCCN Clinical Practice Guidelines in Oncology for Neuroendocrine Tumors discuss the diagnosis and management of both sporadic and hereditary NETs. This selection from the guidelines focuses on sporadic NETs of the pancreas, gastrointestinal tract, lung, and thymus.